Rankings
▼
Calendar
ACRS Q2 2024 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ACRS
Aclaris Therapeutics, Inc.
$435M
Q2 2024 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$3M
+48.0% YoY
Gross Profit
$857,000
31.0% margin
Operating Income
-$13M
-464.7% margin
Net Income
-$11M
-397.2% margin
EPS (Diluted)
$-0.15
QoQ Revenue Growth
+15.3%
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$12M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$161M
Total Liabilities
$27M
Stockholders' Equity
$134M
Cash & Equivalents
$23M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3M
$2M
+48.0%
Gross Profit
$857,000
$277,000
+209.4%
Operating Income
-$13M
-$32M
+59.6%
Net Income
-$11M
-$30M
+62.8%
Revenue Segments
License and Service
$2M
77%
Contract research
$625,000
23%
← FY 2024
All Quarters
Q3 2024 →